Vir Biotechnology, Once a Hot Covid Stock, Finds New Path Forward in Cancer | Barron's

Retrieved on: 2025-01-08 17:04:06

Tags for this article:

Monoclonal antibodies

COVID-19 drug development

Sotrovimab

Sanofi

GSK plc

Alnylam Pharmaceuticals

Click the tags to see associated articles and topics

Vir Biotechnology, Once a Hot Covid Stock, Finds New Path Forward in Cancer | Barron's. View article details on hiswai:

Excerpt

Vir specialized at the time in developing monoclonal antibodies it hoped would treat or prevent infectious diseases. Before the advent of Covid-19 ...

Article found on: www.barrons.com

View Original Article